Skip to main content

Advertisement

Log in

FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

To evaluate the clinical value of 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for the diagnosis of fever of unknown origin (FUO), we performed a Japanese multi-center retrospective survey.

Methods

A total of 81 consecutive patients with FUO who underwent FDG-PET at 6 institutions between July 2006 and December 2007 were retrospectively evaluated. FDG uptake was visually evaluated using a 4-grade scale. The efficacy of FDG-PET for the evaluation of FUO, the provision of additional diagnostic information, the clinical impact on therapeutic decisions (4-grade scale), and the diagnostic performance compared with the final diagnosis were evaluated.

Results

The diagnostic results were analyzed according to 4 groups of final diagnoses: infection, arthritis/vasculitis/autoimmune/collagen disease (A/V), tumor/granuloma (T/G), and other/unknown (O/U). Sensitivity was highest in T/G, followed by infection, A/V and O/U [100%(7/7), 89%(24/27), 65%(11/17), 0%(0/1) respectively]. Clinical impact and mean FDG score showed the same tendency. Additional information was highest in infection followed by T/G, A/V, and O/U [76%(22/29), 75%(6/8), 43%(9/21), 23%(5/22), respectively]. The O/U group showed a high specificity (84%, 16/19) and accurately excluded active focal inflammatory diseases and malignancy. The use of steroids for the treatment of fever seemed to mask the lesions and modified the results, especially in the A/V group (4 false negatives in 8 steroid users out of 21 A/V patients). The prevalence of each disease in each hospital significantly affected the effectiveness of FDG-PET for the diagnosis of FUO. The mean FDG uptake score and additional information (70%, 31/44 vs. 30%, 11/37, respectively) in national hospital (NH) was significantly higher than in university hospitals (UH). A Grade 3 clinical impact, in which the FDG PET results changed the clinical decision, was seen in 50% (22/44) of the patients in the NH group and 13.5% (5/37) of the patients in the UH group. The sensitivity (91%, 30/33; 63%, 12/19) and specificity (60%, 6/10; 86%, 12/14) of the results in the NH and UH groups differed. The total sensitivity was 81% (42/52), specificity was 75% (18/24). The NH group included a large number of cases with infectious diseases (50%, 23/44), while the UH group included a large number of A/V cases (38%, 14/37) and O/U cases (41%, 15/37).

Conclusion

FDG-PET for the diagnosis of FUO provided additional diagnostic information and had a high clinical impact, especially among patients with infectious diseases. It was also helpful in cases with unknown or other miscellaneous diseases by allowing the exclusion of focally active diseases. The prevalence of diseases in hospitals significantly affected the effectiveness of FDG-PET for the diagnosis of FUO. FDG-PET is a useful examination providing various degrees of clinical impact for the management of FUO, depending on the characteristics of the patient and the hospital.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, et al. High [18F]fluorodeoxyglucose uptake in abdominal abscess: a PET study. J Comput Assist Tomogra. 1989;13:829–31.

    Article  CAS  Google Scholar 

  2. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo; high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.

    PubMed  CAS  Google Scholar 

  3. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–6.

    PubMed  CAS  Google Scholar 

  4. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45.

    PubMed  CAS  Google Scholar 

  5. Bleeker-Rovers CP, van der Meer JWM, Oyen WJG. Fever of unknown origin. Semin Nucl Med. 2009;39:81–7.

    Article  PubMed  Google Scholar 

  6. Beckers C, Ribbens C, Andre B, Marcelis S, Kaya O, Mathy L, et al. Assessments of disease activity in rheumatoid arthritis with 18F-FDG PET. J Nucl Med 2004;45:956–64.

    Google Scholar 

  7. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med. 2009;23:783–91.

    Article  PubMed  Google Scholar 

  8. Ito K, Kubota K, Morooka M, Hasuo K, Kuroki H, Mimori A. Clinical impact of 18F-FDG PET/CT on the management and diagnosis of infectious spondylitis. Nucl Med Comm. 2010;31:691–8.

    Article  Google Scholar 

  9. Webb M, Chambers A, AL-Nahhas A, Mason JC, Maudlin L, Rahman L, Frank J. The role of 18F-FDG PET in characterizing disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627–34.

    Article  PubMed  Google Scholar 

  10. Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, Orth T, Schreckenberger M, Galle PR, Bartenstein P. Noninvasive assessment of Crohn`s disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97:1978–85.

    Article  PubMed  CAS  Google Scholar 

  11. Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27:1617–25.

    Article  PubMed  CAS  Google Scholar 

  12. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Clinical value of [18F]fluorodeoxyglucose PET for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191–6.

    Article  PubMed  CAS  Google Scholar 

  13. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Comm. 2001;22:779–83.

    Article  CAS  Google Scholar 

  14. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37.

    Article  PubMed  Google Scholar 

  15. Kjaer A, Lebech AM, Eigtved A, Højgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-grnulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622–6.

    Article  PubMed  Google Scholar 

  16. Buysschaert I, Vnderschueren S, Blockmans D, Mortelmans L, Knockaert D. Conribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151–6.

    Article  PubMed  Google Scholar 

  17. Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff ASM, Geus-Oei LFD, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703.

    Article  PubMed  Google Scholar 

  18. Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980–5.

    Article  PubMed  Google Scholar 

  19. Baling H, Collins J, Bruyn G, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34:862–8.

    Article  Google Scholar 

  20. Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, Pflumio F, et al. Value of 18F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract. 2010;64:55–60.

    Article  PubMed  CAS  Google Scholar 

  21. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1–30.

    Article  PubMed  CAS  Google Scholar 

  22. Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36:504–11.

    Article  PubMed  Google Scholar 

  23. Castaigne C, Tondeur M, De Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Comm. 2009;30:41–7.

    Article  Google Scholar 

  24. Brust D, Polis M, Davey R, Hahn B, Bacharach S, Whatley M, Fauci AS, Carrasquillo JA. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS. 2006;20:495–503.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the Grantin-Aid for Cancer Research (17-12), and by Grant for International Health Research (21A126) from the Ministry of Health, Labor and Welfare Japan, and by a Grant-in-aid for Scientific Research (C) (No. 22591362) from the Ministry of Education, Culture, Sports Science, and Technology Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuo Kubota.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubota, K., Nakamoto, Y., Tamaki, N. et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med 25, 355–364 (2011). https://doi.org/10.1007/s12149-011-0470-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-011-0470-6

Keywords

Navigation